CM-24 (MK-6018) is a humanized antibody targeting CEACAM1, an effective blocker of the CEACAM1-CEACAM1 interaction between cells, reversing the inhibition of activated lymphocytes by restoring ZAP70 phosphorylation, which can be used to study pancreatic cancer and colon adenocarcinoma.
Purity:
>95%
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted